SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The turnover soared 64.92% to Rs. 22512.80 millions for the December 2024 quarter as compared to Rs. 13650.96 millions during the corresponding quarter last year.The Total Profit for the quarter ended December 2024 of Rs. 4138.03 millions grew from Rs.-204.09 millionsOperating profit surged to 6231.16 millions from the corresponding previous quarter of 745.47 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 22512.80 13650.96 64.92 72169.16 57428.96 25.67 78911.19 82206.62 -4.01
Other Income 1291.89 2588.15 -50.08 2679.14 3817.54 -29.82 11680.24 9859.39 18.47
PBIDT 6231.16 745.47 735.87 21715.69 11259.72 92.86 24096.87 24587.06 -1.99
Interest 84.62 736.04 -88.50 356.06 1937.25 -81.62 2771.10 2068.16 33.99
PBDT 6146.54 -243.40 -2625.28 21359.63 8556.66 149.63 72029.08 17560.22 310.18
Depreciation 551.64 511.62 7.82 1631.00 1497.60 8.91 2021.62 1841.48 9.78
PBT 5594.90 -755.02 -841.03 19728.63 7059.06 179.48 70007.46 15718.74 345.38
TAX 1456.87 -550.93 -364.44 5102.73 1523.05 235.03 18334.55 3631.05 404.94
Deferred Tax 504.26 -19.26 -2718.17 1685.65 1576.92 6.90 7834.63 -238.26 -3388.27
PAT 4138.03 -204.09 -2127.55 14625.90 5536.01 164.20 51672.91 12087.69 327.48
Equity 282.19 282.17 0.01 282.19 282.17 0.01 282.19 282.17 0.01
PBIDTM(%) 27.68 5.46 406.85 30.09 19.61 53.47 30.54 29.91 2.10

Glenmark Pharma Share Price

2337.20 95.65 (4.27%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×